Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal intelligence from Strategic Transactions.
Valeant Pharmaceuticals International Inc. announced July 17 that it is selling off its Obagi Medical Products Inc. subsidiary...








